United Kingdom: A new study has stated that most women diagnosed with early-stage breast cancer can expect to become long-term survivors, with some having a risk of death within five years as low as 0.2 percent. The research, funded by Cancer Research UK, brings reassuring news to women battling breast cancer.
Led by academics at the University of Oxford, the study tracked survival rates among half a million women diagnosed with breast cancer in England from 1993 to 2015, focusing on cases where cancer had not spread beyond the breast. The researchers assessed the risk of death five years after diagnosis, when the likelihood of death from breast cancer is highest.
The findings showed a significant improvement in survival rates. Women diagnosed between 2010 and 2015 had a 66 percent lower risk of dying from the disease within five years compared to those diagnosed in the 1990s. The study revealed that the risk of death within five years dropped from 14.4 percent for women diagnosed between 1993 and 1999 to 4.9 percent for women diagnosed between 2010 and 2015.
The authors of the study emphasised the improved prognosis for women with early-stage invasive breast cancer since the 1990s, stating that most can expect to be long-term survivors. Dr. Carolyn Taylor, the lead author, expressed optimism about the findings, noting that the risk of dying from breast cancer in the first five years after diagnosis is now 5 percent.
The study also highlighted the potential drivers behind the improved survival rates, including advancements in treatments, radiotherapy, detection methods, breast screening, and a better understanding of the diverse characteristics of breast cancer.
The results of this research provide hope for the majority of women diagnosed with early-stage breast cancer and may contribute to more accurate prognosis predictions in clinical settings. Further research in the future could potentially lead to even lower breast cancer death rates for women diagnosed with early-stage breast cancer.